A recent global survey by Marks & Clerk, the UK patent firm, suggests that big pharma is rapidly approaching a “patent cliff” and will be more dependent than ever on its biotech brethren for the development of successful and profitable drugs in the years ahead. The survey found that bio/pharm may be entering an even [...]